Production (Stage)
Tectonic Therapeutic, Inc.
TECX
$21.65
-$0.55-2.48%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 19.76M | 16.65M | 14.00M | 10.66M | 8.18M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 63.35M | 58.02M | 53.40M | 43.88M | 43.09M |
| Operating Income | -63.35M | -58.02M | -53.40M | -43.88M | -43.09M |
| Income Before Tax | -58.67M | -57.98M | -53.48M | -45.82M | -43.60M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -58.67 | -57.98 | -53.48 | -45.82 | -43.60 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -58.67M | -57.98M | -53.48M | -45.82M | -43.60M |
| EBIT | -63.35M | -58.02M | -53.40M | -43.88M | -43.09M |
| EBITDA | -61.72M | -56.37M | -51.89M | -42.42M | -41.60M |
| EPS Basic | -7.31 | -17.35 | -22.40 | -28.82 | -32.99 |
| Normalized Basic EPS | -4.57 | -10.84 | -14.00 | -18.01 | -20.62 |
| EPS Diluted | -7.31 | -17.35 | -22.40 | -28.82 | -32.99 |
| Normalized Diluted EPS | -4.57 | -10.84 | -14.00 | -18.01 | -20.62 |
| Average Basic Shares Outstanding | 49.60M | 33.83M | 20.37M | 6.96M | 5.27M |
| Average Diluted Shares Outstanding | 49.60M | 33.83M | 20.37M | 6.96M | 5.27M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |